| Literature DB >> 31929943 |
Andrea Mariela Araya-Sibaja1,2,3, Carlos Eduardo Maduro de Campos4, Cinira Fandaruff5, José Roberto Vega-Baudrit1,6, Teodolito Guillén-Girón2, Mirtha Navarro-Hoyos3, Silvia Lucía Cuffini7.
Abstract
Irbesartan (IBS) is a tetrazole derivative and antihypertensive drug that has two interconvertible structures, 1H- and 2H-tautomers. The difference between them lies in the protonation of the tetrazole ring. In the solid-state, both tautomers can be isolated as crystal forms A (1H-tautomer) and B (2H-tautomer). Studies have reported that IBS is a polymorphic system and its forms A and B are related monotropically. These reports indicate form B as the most stable and less soluble form. Therefore, the goal of this contribution is to demonstrate through a complete solid-state characterization, thermodynamic study and dissolution properties that the IBS forms are desmotropes that are not related monotropically. However, the intention is also to call attention to the importance of conducting strict chemical and in solid-state quality controls on the IBS raw materials. Hence, powder X-ray diffraction (PXRD) and Raman spectroscopy (RS) at ambient and non-ambient conditions, differential scanning calorimetry (DSC), hot stage microscopy (HSM), Fourier transform infrared (FT-IR) and scanning electron microscopy (SEM) techniques were applied. Furthermore, intrinsic dissolution rate (IDR) and structural stability studies at 98% relative humidity (RH), 25 °C and 40 °C were conducted as well. The results show that in fact, form A is approximately four-fold more soluble than form B. In addition, both IBS forms are stable at ambient conditions. Nevertheless, structural and/or chemical instability was observed in form B at 40 °C and 98% RH. IBS has been confirmed as a desmotropic system rather than a polymorphic one. Consequently, forms A and B are not related monotropically.Entities:
Keywords: Desmotropic forms; Intrinsic dissolution rate; Irbesartan; Solid-state characterization; Tautomerism
Year: 2019 PMID: 31929943 PMCID: PMC6951487 DOI: 10.1016/j.jpha.2019.07.001
Source DB: PubMed Journal: J Pharm Anal ISSN: 2214-0883
Fig. 1Chemical structure of irbesartan and tautomerism in the tetrazole system (adapted from Ref. [22]).
Crystal forms of IBS already reported in the literature.
| Crystal form | Description |
|---|---|
| Form A | Crystal structure not reported in CSD |
| 1 | Trigonal ( |
| 2 | Monoclinic (P21/c) according to Ref. [ |
| 3 | Hexagonal system according to Ref. [ |
| 4 | Trigonal ( |
| b: 37.269 Å β: 90.0° | |
| c: 9.793 Å γ: 120.0° | |
| V: 11779.91 Å3 | |
| Z: 18 | |
| 5 | Monoclinic (P2) according to ICDD PDF-4 Organics 2018 [ |
| b: 18.901 Å β: 98.27° | |
| c: 9.508 Å γ: 90.00 | |
| V: 1950.76 Å3 | |
| Z: 4.00 | |
| Form B | CCSD ref code: NOZWII |
| Triclinic ( | |
| b: 12.181 Å β: 105.24° | |
| c: 9.366 Å γ: 112.92° | |
| V: 1122.9 Å3 | |
| Z: 2 | |
| Hydrochloride 1.69-hydrate | CCSD ref code: LIBZAY |
| Monoclinic (P21/a) [ | |
| b: 25.0130 Å β: 104.415° | |
| c: 12.2675 Å γ: 90.00° | |
| V: 2542.64 Å3 | |
| Z: 4 | |
| Bromide sesquihydrate | CCSD ref code: NIQVIT |
| Monoclinic (P21/c) [ | |
| b: 25.285 Å β: 105.78° | |
| c: 8.6938 Å γ: 90.00° | |
| V: 2640.4 Å3 | |
| Z: 2 | |
| IBS: Hippuric acid cocrystal | Crystal structure not reported [ |
Fig. 2PXRD pattern of IBS desmotropic forms: (A) experimental form A and (B) experimental and calculated form B (NOZWII crystallographic data).
Fig. 3IBS desmotropic forms A and B: (A) FT-IR spectra and (B) Raman spectra.
Fig. 4SEM micrographs of both IBS desmotropes: (A) form A and (B) form B.
Fig. 5DSC curves and inserted HSM images of IBS desmotropic forms A and B.
Fig. 6Non-ambient temperature PXRD patterns of IBS solid forms: (A) form A and (B) form B.
Fig. 7Non-ambient temperature Raman spectra of IBS solid forms: (A) form A and (B) form B.
Fig. 8IDR profile of both IBS desmotropes.
Fig. 9PXRD patterns of IBS form B at different times of storage at 98% RH and 40 °C.